Supernus Pharmaceuticals (SUPN) Return on Capital Employed (QoQ) (2012 - 2025)
Supernus Pharmaceuticals (SUPN) Return on Capital Employed (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.73 Bn | 2.36 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -222.00 |
| Sep 30, 2025 | -940.00 |
| Jun 30, 2025 | -98.00 |
| Mar 31, 2025 | -75.00 |
| Dec 31, 2024 | 197.00 |
| Sep 30, 2024 | 306.00 |
| Jun 30, 2024 | 405.00 |
| Mar 31, 2024 | -86.00 |
| Dec 31, 2023 | -353.00 |
| Sep 30, 2023 | 142.00 |
| Jun 30, 2023 | -328.00 |
| Mar 31, 2023 | 29.00 |
| Dec 31, 2022 | 272.00 |
| Sep 30, 2022 | -373.00 |
| Jun 30, 2022 | 16.00 |
| Mar 31, 2022 | -116.00 |
| Dec 31, 2021 | -266.00 |
| Sep 30, 2021 | -241.00 |
| Jun 30, 2021 | 48.00 |
| Mar 31, 2021 | -221.00 |